Divergent antioxidant capacity of human islet cell subsets: A potential cause of beta-cell vulnerability in diabetes and islet transplantation

被引:73
|
作者
Miki, Atsushi [1 ,4 ]
Ricordi, Camillo [1 ]
Sakuma, Yasunaru [1 ,4 ]
Yamamoto, Toshiyuki [1 ,5 ]
Misawa, Ryosuke [1 ,6 ]
Mita, Atsuyoshi [1 ,6 ]
Molano, Ruth D. [1 ]
Vaziri, Nosratola D. [2 ]
Pileggi, Antonello [1 ]
Ichii, Hirohito [1 ,3 ,7 ]
机构
[1] Univ Miami, Cell Transplant Ctr, Diabet Res Inst, Miami, FL 33124 USA
[2] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA
[3] Univ Calif Irvine, Dept Surg, Irvine, CA 92717 USA
[4] Jichi Med Univ, Dept Surg, Shimotsuke, Tochigi, Japan
[5] Fujita Hlth Univ, Dept Surg, Toyoake, Aichi, Japan
[6] Shinshu Univ, Dept Surg, Matsumoto, Nagano, Japan
[7] Univ Calif Irvine, Dept Surg, Irvine, CA 92717 USA
来源
PLOS ONE | 2018年 / 13卷 / 05期
关键词
HUMAN PANCREATIC-ISLETS; LASER-SCANNING CYTOMETRY; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE; ALLOGRAFT-REJECTION; RADICAL SCAVENGER; OXIDATIVE STRESS; NITRIC-OXIDE; DNA-DAMAGE; MASS;
D O I
10.1371/journal.pone.0196570
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Type 1 and Type 2 diabetes mellitus (T1DM and T2DM) are caused by beta(beta)-cell loss and functional impairment. Identification of mechanisms of beta-cell death and therapeutic interventions to enhance beta-cell survival are essential for prevention and treatment of diabetes. Oxidative stress is a common feature of both T1DM and T2DM; elevated biomarkers of oxidative stress are detected in blood, urine and tissues including pancreas of patients with DM. Islet transplantation is a promising treatment for diabetes. However, exposure to stress (chemical and mechanical) and ischemia-reperfusion during isolation and transplantation causes islet loss by generation of reactive oxygen species (ROS). Human intracellular antioxidant enzymes and related molecules are essential defenses against ROS. Antioxidant enzyme levels including superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPX) have been shown to be low in islet cells. However, little is known about the expression and function of antioxidant enzymes within islet cell subsets. We evaluated the expression of the key antioxidant enzymes in beta- and alpha(alpha)-cell and accessed effects of oxidative stress, islet isolation and transplantation on beta/alpha-cell ratio and viability in human islets. Methods Human pancreata from T1DM, T2DM and non-diabetic deceased donors were obtained and analyzed by confocal microscopy. Isolated islets were (I) transplanted in the renal sub-capsular space of streptozotocin-induced diabetic nude mice (in vivo bioassay), or II) exposed to oxidative (H2O2) and nitrosative (NO donor) stress for 24 hrs in vitro. The ratio, % viability and death of beta- and alpha-cells, and DNA damage (8OHdG) were measured. Results and conclusions Catalase and GPX expression was much lower in beta- than alpha-cells. The beta/alpha-cell ratio fells significantly following islet isolation and transplantation. Exposure to oxidative stress caused a significantly lower survival and viability, with higher DNA damage in beta- than alpha-cells. These findings identified the weakness of beta-cell antioxidant capacity as a main cause of vulnerability to oxidative stress. Potential strategies to enhance beta-cell antioxidant capacity might be effective in prevention/treatment of diabetes.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] ADENOMA OF THE BETA-CELL OF THE PANCREATIC-ISLET
    NOGUEIRA, CED
    ZIVIANI, N
    MARTINS, FP
    RIBEIRO, M
    ANDRADE, NA
    DIGESTIVE DISEASES AND SCIENCES, 1986, 31 (10) : S61 - S61
  • [22] STIMULATION OF ISLET BETA-CELL REPLICATION BY ONCOGENES
    WELSH, M
    WELSH, N
    NILSSON, T
    ARKHAMMAR, P
    STEINER, DF
    BERGGREN, PO
    CLINICAL GENETICS, 1988, 33 (06) : 470 - 470
  • [23] Targeting Beta-Cell Heterogeneity in the Islet of Langerhans
    Bader, Erik
    Migliorini, Adriana
    Gegg, Moritz
    Irmler, Martin
    Beckers, Johannes
    Chmelova, Helena
    Chouinard, Julie A.
    Speier, Stephan
    Lickert, Heiko
    DIABETES, 2015, 64 : A581 - A581
  • [24] Induction of beta-cell neogenesis by islet injury
    Teitelman, G
    DIABETES-METABOLISM REVIEWS, 1996, 12 (02): : 91 - 102
  • [25] Integration of nano- and biotechnology for beta-cell and islet transplantation in type-1 diabetes treatment
    Dinnyes, Andras
    Schnur, Andrea
    Muenthaisong, Suchitra
    Bartenstein, Peter
    Burcez, Charles-Thibault
    Burton, Neal
    Cyran, Clemens
    Gianello, Pierre
    Kemter, Elisabeth
    Nemeth, Gabor
    Nicotra, Francesco
    Prepost, Eszter
    Qiu, Yi
    Russo, Laura
    Wirth, Andras
    Wolf, Eckhard
    Ziegler, Sibylle
    Kobolak, Julianna
    CELL PROLIFERATION, 2020, 53 (05)
  • [26] ISLET CELL TRANSPLANTATION IN TREATMENT OF DIABETES
    NAJARIAN, JS
    HOSPITAL PRACTICE, 1977, 12 (10): : 63 - 69
  • [27] PANCREAS AND ISLET-CELL TRANSPLANTATION - POTENTIAL CURE FOR DIABETES
    SOONSHIONG, P
    LANZA, RP
    POSTGRADUATE MEDICINE, 1990, 87 (08) : 133 - &
  • [28] Proinflammatory Cytokines Impair Human Islet and Beta-Cell Glucose Oxidation
    Melo, Joana
    Jensen, Verena Hirschberg
    Storling, Joachim
    DIABETES, 2020, 69
  • [29] Donor insulin use predicts beta-cell function after islet transplantation
    Shapey, Iestyn M.
    Summers, Angela
    Yiannoullou, Petros
    Khambalia, Hussein
    Fullwood, Catherine
    Hanley, Neil A.
    Casey, John
    Forbes, Shareen
    Rosenthal, Miranda
    Johnson, Paul R., V
    Choudhary, Pratik
    Bushnell, James
    Shaw, James A. M.
    Augustine, Titus
    Rutter, Martin K.
    van Dellen, David
    DIABETES OBESITY & METABOLISM, 2020, 22 (10): : 1874 - 1879
  • [30] Donor parameters of pancreas grafts processed for islet or beta-cell isolation and transplantation
    Hesse, UJ
    Berrevoet, F
    Pattyn, P
    Vanholder, R
    deHemptinne, B
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (04) : 2259 - 2259